MGLL and central nervous system disorder: Considering these assumptions, the present review aims to offer a glimpse of the current polypharmacological approaches involving FAAH and MAGL inhibitors, their dualism, and their polypharmacology involving other enzymes or systems with a focus on CNS disorders and especially neurodegenerative ones.